Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. (Q43573420)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2001
edit
Language Label Description Also known as
English
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.
scientific article published in February 2001

    Statements

    Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study (English)
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit